Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplantJohn J. Friedewald, Michaël Abécassis, Merideth M. Brown et al.|American Journal of Transplantation|2018Cited by 156
Molecular Classifiers for Acute Kidney Transplant Rejection in Peripheral Blood by Whole Genome Gene Expression ProfilingSunil M. Kurian, Daniel R. Salomon, Alun Williams et al.|American Journal of Transplantation|2014Cited by 114
Gene Expression in Biopsies of Acute Rejection and Interstitial Fibrosis/Tubular Atrophy Reveals Highly Shared Mechanisms That Correlate With Worse Long‐Term OutcomesBrian D. Modena, Daniel R. Salomon, Sunil M. Kurian et al.|American Journal of Transplantation|2016Cited by 110
Combining Blood Gene Expression and Cellfree DNA to Diagnose Subclinical Rejection in Kidney Transplant RecipientsSookhyeon Park, John J. Friedewald, Kexin Guo et al.|Clinical Journal of the American Society of Nephrology|2021Cited by 82